Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...

Diabetes management isn't just about medication; it's also about making informed food choices. With World Diabetes Day around ...

Combined with a monthly Universal Credit payment of £393.45 (over-25 rate), this could provide up to £1,130.65 each month. It’s important to be aware that this figure is based on someone receiving the ...